This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Headquartered in Woonsocket, RI, CVS Health Corporation (formerly known as CVS Caremark Corporation) is a pharmacy innovation company with integrated offerings across the entire spectrum of pharmacy care. On Sep 3, 2014, CVS Caremark Corporation announced a change of its corporate name to CVS Health to reflect its broader health care commitment. In Nov 2018, CVS Health completed the $70-billion consolidation of insurance-giant Aetna. With the acquisition, the segments of CVS Health have been realigned.
CVS Health (CVS) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $87.68, marking a +0.18% move from the previous day.
Here's Why You Should Hold on to Walgreens Boots (WBA) for Now
by Zacks Equity Research
Investors are optimistic about Walgreens Boots (WBA) given its better-than-expected fourth-quarter fiscal 2021 results and strategic alliances.
CVS Health (CVS) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $84.48, marking a -1.58% move from the previous day.
NextGen's (NXGN) Integrated Platform Gets Leveraged by Mednax
by Zacks Equity Research
Mednax utilizes NextGen's (NXGN) fully-integrated platform to enhance its efficacy in placing crucial information on patients' health and well-being at the physician's fingertips.
Will CVS Health (CVS) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Is CVS Health (CVS) Stock Outpacing Its Retail-Wholesale Peers This Year?
by Zacks Equity Research
Is (CVS) Outperforming Other Retail-Wholesale Stocks This Year?
CVS Health (CVS) Stock Moves -0.11%: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed the most recent trading day at $84.28, moving -0.11% from the previous trading session.
Quidel Corporation (QDEL) Reports Solid Preliminary Q3 Revenues
by Zacks Equity Research
Quidel's (QDEL) revenue growth in the third quarter is likely to have been boosted by robust sales of its SARS-related products.
Top Analyst Reports for Pfizer, American Tower & Intuitive Surgical
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Pfizer Inc. (PFE), American Tower Corporation (AMT), and Intuitive Surgical, Inc. (ISRG).
CVS Health (CVS) Stock Moves -0.31%: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed at $83.81 in the latest trading session, marking a -0.31% move from the prior day.
Here's Why You Should Retain CVS Health (CVS) Stock For Now
by Zacks Equity Research
Investors are optimistic about CVS Health (CVS) on growth in the company's specialty digital solutions and a bullish 2021 outlook.
CVS Health (CVS) Gains As Market Dips: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed at $85.74 in the latest trading session, marking a +1.22% move from the prior day.
CVS Health (CVS) Retail Business Grows Despite Cost Pressure
by Zacks Equity Research
CVS Health's (CVS) retail business sees solid rebound in front-store sales with strength across all categories.
The Zacks Analyst Blog Highlights: United Parcel Service, ServiceNow, CVS Health, Booking Holdings and Altria Group
by Zacks Equity Research
The Zacks Analyst Blog Highlights: United Parcel Service, ServiceNow, CVS Health, Booking Holdings and Altria Group
Top Stock Reports for United Parcel Service, ServiceNow & CVS Health
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including United Parcel Service, Inc. (UPS), ServiceNow, Inc. (NOW), and CVS Health Corporation (CVS).
Here's Why You Should Retain Walgreens (WBA) Stock for Now
by Zacks Equity Research
Investors are optimistic about Walgreens (WBA), given the strong performance in the International segment and notable product launches.
CVS Health (CVS) Stock Moves -1.09%: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $84.58, marking a -1.09% move from the previous day.
CVS Health (CVS) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $84.51, marking a +0.86% move from the previous day.
The Zacks Analyst Blog Highlights: Verizon, CVS Health, BHP Group, Autodesk and DISH Network
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Verizon, CVS Health, BHP Group, Autodesk and DISH Network
Top Stock Reports for Verizon, CVS Health & BHP
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Verizon Communications Inc. (VZ), CVS Health Corporation (CVS), and BHP Group (BHP).
CVS Health (CVS) Up 8.6% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
CVS Health (CVS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Quidel's (QDEL) QuickVue OTC COVID-19 Test Now Widely Available
by Zacks Equity Research
In-store and online availability of Quidel's (QDEL) QuickVue OTC COVID-19 Test is expected to meet the rising COVID-19 testing needs across the United States.
Workday (WDAY) Q2 Earnings & Revenues Beat Estimates, Up Y/Y
by Zacks Equity Research
Workday's (WDAY) fiscal second-quarter results benefit from high demand for its cloud-based HCM and financial management solutions.
CVS Health (CVS) Q2 Earnings Beat Estimates, EPS View Up
by Zacks Equity Research
CVS Health (CVS) Q2 adjusted EPS drops year over year on escalating costs and expenses which are putting pressure on margins.
Weak Private Payrolls Data Pulls Futures Lower
by Zacks Equity Research
Weak Private Payrolls Data Pulls Futures Lower